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Background
Early gadolinium enhancement (EGE) has been indi-
cated as major CMR criterion for the diagnosis of myo-
carditis according to the Lake Louise consensus (LLC).
However, the suggested threshold of 4.0 for Early
enhancement ratio (EER) specifically refers to use of
conventional Gd-chelates (gadopentetate dimeglumine).
Our purpose was to evaluate performance of a high
relaxivity contrast agent (gadobenate dimeglumine) for
the detection of EGE applying the suggested cut-off.
Methods
57 consecutive patients with a histologically-proven diag-
nosis of acute myocarditis and 18 controls performed a
CMR study on a 1.5T unit. CMR protocol included: T2w-
STIR sequences, early gadolinium enhancement (EGE)
and late gadolinium enhancement (LGE) technique after a
single bolus of 0.1mmol/Kg Gd-BOPTA. For each study
early myocardial enhancement ratio was calculated as fol-
lows: early gadolinium enhancement ratio = enhancement
myocardium/enhancement skeletal muscle. In patients
with evidence for skeletal muscle involvement, an absolute
myocardial enhancement of more than 45% was consid-
ered as diagnostic criterion. Receiver operating character-
istic (ROC) curve analysis was applied on the overall
population.
Results
EGE was present in 35 patients with myocarditis. Apply-
ing the EGE threshold proposed by LLC (EER
value>4.0) to the ROC curve, sensitivity and specificity
of respectively 60.7% and 88.9% (area under curve:
0.722) were observed. These results are comparable to
whose obtained by using gadopentetate dimeglumine
reported in literature.
Conclusions
Use of Gd-BOPTA provides comparable results to con-
ventional Gd chelates regarding the application of EGE
suggested thresholds for the diagnosis of acute myocar-
ditis and it is therefore applicable in daily clinical
routine.
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